NRC Issues Exemptions to Three Nuclear Plant Operators
Published Date: 4/16/2026
Notice
Summary
The Nuclear Regulatory Commission gave three special permissions to three different nuclear plant operators between January and March 2026. These exemptions let the operators do things a bit differently than usual, helping them run smoother without extra costs or delays. If you’re involved with these plants, keep an eye on these changes—they’re official and already in effect!
No Economic Impacts Identified for this Document
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-08015, Generic Environmental Impact Statement for Licensing of New Nuclear Reactors
The Nuclear Regulatory Commission just updated the rules for checking the environmental impact of new nuclear reactors. This makes it easier and faster to review many reactors by using a common set of environmental factors, while still looking closely at unique site details. The new rules kick in on May 26, 2026, helping companies and communities plan ahead with clearer, smarter guidelines.
2026-06048, Risk-Informed, Technology-Inclusive Regulatory Framework for Advanced Reactors
The Nuclear Regulatory Commission is updating its rules to make it easier and safer to approve new types of nuclear reactors, including advanced designs that don’t use traditional water cooling. This change affects companies building future nuclear plants and aims to speed up licensing while keeping safety top-notch. The new rules kick in on April 29, 2026, helping innovation move forward without extra costs or delays.
2025-14147, Fee Schedules; Fee Recovery for Fiscal Year 2025
The U.S. Nuclear Regulatory Commission fixed a typo in their fee schedule for 2025. This update affects companies and government agencies that pay licensing and inspection fees, making sure the right amounts are charged. The corrected fees kick in soon, so everyone can plan their budgets without surprises!
2025-11544, Fee Schedules; Fee Recovery for Fiscal Year 2025
The U.S. Nuclear Regulatory Commission is updating its fees for licenses, inspections, and special projects starting in fiscal year 2025. These changes make sure the NRC recovers nearly all its costs, while giving a break with lower hourly rates for advanced nuclear reactor applicants. If you’re involved with nuclear licensing or inspections, get ready for new fees and some savings on cutting-edge tech!
2025-02779, Fee Schedules; Fee Recovery for Fiscal Year 2025
The U.S. Nuclear Regulatory Commission is updating its fees for licenses, inspections, and special projects starting in fiscal year 2025. These changes make sure the NRC covers almost all its costs, while giving a discount to advanced nuclear reactor applicants. If you’re involved with nuclear licensing or inspections, get ready for new fees and some savings on cutting-edge tech!
2026-09778, State of Indiana: NRC Staff Assessment of a Proposed Agreement Between the Nuclear Regulatory Commission and the State of Indiana
The Nuclear Regulatory Commission (NRC) is working with Indiana to take over some nuclear safety rules from the federal government. This means Indiana will handle more local nuclear oversight, which could speed up decisions and keep communities safer. People have until June 15, 2026, to share their thoughts before the plan moves forward—no big costs are expected, just smarter teamwork!
Previous / Next Documents
Previous: 2026-07449, Commodity Matchbooks From India; Scheduling of Expedited Five-Year Reviews
The U.S. International Trade Commission is speeding up its review to decide if special taxes on matchbooks from India should stay or go. This affects U.S. businesses that make or sell matchbooks and could impact prices or trade rules soon. The review started on March 16, 2026, and aims to protect American companies from unfair competition.
Next: 2026-07451, Determination That REVIA (Naltrexone Hydrochloride) Tablets, 50 Milligrams Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that REVIA (naltrexone hydrochloride) 50 mg tablets were not taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions of REVIA, keeping options open for patients and pharmacies. No changes in safety rules or extra costs are expected, so everyone can breathe easy and keep using or making this medicine.